News Gilead donates Truvada to HIV trial patients PROUD trial patients can continue treatment for six months.
Articles Catching cancer early: NHS pioneers new approaches England's health service is raising awareness of cancer and working with medical device firm Covidien to launch a cheaper and faster diagnostic to help tackle oesophago-gastric cancers.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
